Hill-Rom Holdings (NYSE:HRC) landed 510(k) clearance from the FDA for its MetaNeb 4.0 airway clearing system, which combines airway oscillation and pressure to expand weak lungs and encourage normal mucus growth.
The Batesville, Ind.-based company is slated to begin shipping the MetaNeb next month. Like the older version, this device has been cleared for in-hospital use in patients with certain respiratory disease states like bronchitis, cystic fibrosis and asthma.
"The design enhancements to the MetaNeb System represent another great example of Hill-Rom’s dedication to improving outcomes for patients and their caregivers," said Greg Pritchard, senior VP of respiratory care, in prepared remarks.
Michael Roux, former product director of the respiratory division at Hill-Rom, recently departed to become product management VP at SurgiCount, a subsidiary of Patient Safety Technologies (OTC:PSTX).